Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells

HOME

HELP

FEEDBACK

SUBSCRIPTIONS

Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells

TC Chambers, EM McAvoy, JW Jacobs and G Eilon
Department of Biological Chemistry, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Studies were undertaken to identify the protein kinase(s) responsible for P-glycoprotein phosphorylation in multidrug-resistant (KB-V1) human carcinoma cells and to elucidate the functional role of phosphorylation. P-glycoprotein migrated on sodium dodecyl sulfate gels with apparent Mr 150,000 and is termed P150. When KB-V1 membrane vesicles were incubated with [gamma-32P] ATP, P150 was phosphorylated by an endogenous kinase that exhibited properties of membrane-inserted protein kinase C (PKC). Both membrane-bound P150 and purified P150 served as effective substrates for highly purified rat brain PKC which incorporated approximately 0.6 mol of phosphate/mol of P150. Enzyme assays showed that KB-V1 cells exhibit 4-fold higher PKC activity compared with the drug-sensitive KB-3 cell line. The basal phosphorylation of P150 observed in 32P-labeled cells was increased 2- fold by phorbol ester (PMA) treatment and reduced 30% by treatment with the isoquinolinsulfonamide H-7. Phosphopeptide maps of partially digested P150, phosphorylated either in vitro with PKC or in intact 32P- labeled control or PMA-stimulated cells, were indistinguishable from one another. Drug accumulation assays revealed that PMA treatment of KB- V1 cells significantly reduced [3H]vinblastine accumulation induced by verapamil or by tetrandrine. The results suggest that PKC is primarily responsible for P150 phosphorylation in KB-V1 cells and that phosphorylation may play a modulatory role in the drug transport process.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

D. S. Miller, B. Bauer, and A. M. S. Hartz
Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System Pharmacotherapy
Pharmacol. Rev., June 1, 2008; 60(2): 196 - 209.
[Abstract] [Full Text] [PDF]

M.-A. Ghetie, R. Marches, S. Kufert, and E. S. Vitetta
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line
Blood, July 1, 2004; 104(1): 178 - 183.
[Abstract] [Full Text] [PDF]

Y. Yamauchi, M. Hayashi, S. Abe-Dohmae, and S. Yokoyama
Apolipoprotein A-I Activates Protein Kinase C{alpha} Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein Assembly
J. Biol. Chem., November 28, 2003; 278(48): 47890 - 47897.
[Abstract] [Full Text] [PDF]

G. L. Guo and C. D. Klaassen
Protein Kinase C Suppresses Rat Organic Anion Transporting Polypeptide 1- and 2-Mediated Uptake
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 551 - 557.
[Abstract] [Full Text] [PDF]

Y. Yatomi, T. Ohmori, G. Rile, F. Kazama, H. Okamoto, T. Sano, K. Satoh, S. Kume, G. Tigyi, Y. Igarashi, et al.
Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells
Blood, November 15, 2000; 96(10): 3431 - 3438.
[Abstract] [Full Text] [PDF]

K. Szabo, E. Bakos, E. Welker, M. Muller, H. R. Goodfellow, C. F. Higgins, A. Varadi, and B. Sarkadi
Phosphorylation Site Mutations in the Human Multidrug Transporter Modulate Its Drug-stimulated ATPase Activity
J. Biol. Chem., September 12, 1997; 272(37): 23165 - 23171.
[Abstract] [Full Text] [PDF]

J. S. Glavy, S. B. Horwitz, and G. A. Orr
Identification of the in Vivo Phosphorylation Sites for Acidic-directed Kinases in Murine mdr1b P-glycoprotein
J. Biol. Chem., February 28, 1997; 272(9): 5909 - 5914.
[Abstract] [Full Text] [PDF]

G. Chen, G. E. Duran, K. A. Steger, N. J. Lacayo, J.-P. Jaffrezou, C. Dumontet, and B. I. Sikic
Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins
J. Biol. Chem., February 28, 1997; 272(9): 5974 - 5982.
[Abstract] [Full Text] [PDF]

R. L. Fine, T. C. Chambers, and C. W. Sachs
P-Glycoprotein, Multidrug Resistance and Protein Kinase C
Oncologist, August 1, 1996; 1(4): 261 - 268.
[Abstract] [Full Text] [PDF]

H. R. Goodfellow, A. Sardini, S. Ruetz, R. Callaghan, P. Gros, P. A. McNaughton, and C. F. Higgins
Protein Kinase C-mediated Phosphorylation Does Not Regulate Drug Transport by the Human Multidrug Resistance P-glycoprotein
J. Biol. Chem., June 7, 1996; 271(23): 13668 - 13674.
[Abstract] [Full Text] [PDF]

K. P. Gupta, N. E. Ward, K. R. Gravitt, P. J. Bergman, and C. A. O'Brian
Partial Reversal of Multidrug Resistance in Human Breast Cancer Cells by an N-Myristoylated Protein Kinase C-alpha Pseudosubstrate Peptide
J. Biol. Chem., January 26, 1996; 271(4): 2102 - 2111.
[Abstract] [Full Text] [PDF]

R. Fine, T. Chambers, and C. Sachs
P-glycoprotein, multidrug resistance and protein kinase C
Stem Cells, January 1, 1996; 14(1): 47 - 55.
[Abstract]

C. D. Smith and J. T. Zilfou
Circumvention of P-glycoprotein-mediated Multiple Drug Resistance by Phosphorylation Modulators Is Independent of Protein Kinases
J. Biol. Chem., November 24, 1995; 270(47): 28145 - 28152.
[Abstract] [Full Text] [PDF]

M. Tominaga, T. Tominaga, A. Miwa, and Y. Okada
Volume-sensitive Chloride Channel Activity Does Not Depend on Endogenous P-glycoprotein
J. Biol. Chem., November 17, 1995; 270(46): 27887 - 27893.
[Abstract] [Full Text] [PDF]

C. W. Sachs, A. R. Safa, S. D. Harrison, and R. L. Fine
Partial Inhibition of Multidrug Resistance by Safingol Is Independent of Modulation of P-glycoprotein Substrate Activities and Correlated with Inhibition of Protein Kinase C
J. Biol. Chem., November 3, 1995; 270(44): 26639 - 26648.
[Abstract] [Full Text] [PDF]